Stathmin 1 is involved in the highly proliferative phenotype of high-risk myelodysplastic syndromes and acute leukemia cells (2013)
- Autores:
- Machado Neto, João Agostinho - Universidade Estadual de Campinas (UNICAMP)
- Campos, Paula de Melo - Universidade Estadual de Campinas (UNICAMP)
- Favaro, Patricia - Universidade Federal de São Paulo (UNIFESP)
- Lazarini, Mariana - Universidade Estadual de Campinas (UNICAMP)
- Lorand-Metze, Irene - Universidade Estadual de Campinas (UNICAMP)
- Costa, Fernando Ferreira - Universidade Estadual de Campinas (UNICAMP)
- Saad, Sara Teresinha Ollala - Universidade Estadual de Campinas (UNICAMP)
- Traina, Fabíola
- Machado Neto, João Agostinho - Universidade Estadual de Campinas (UNICAMP)
- Autor USP: TRAINA, FABÍOLA - FMRP
- Unidade: FMRP
- Assuntos: LEUCEMIA MIELOIDE AGUDA; HEMATOLOGIA
- Idioma: Inglês
- Imprenta:
- Local: New Orleans
- Data de publicação: 2013
- Fonte:
- Título do periódico: Abstracts, Program and Personal Scheduler
- Nome do evento: Annual Meeting and Exposition of American Society of Hematology (ASH)
-
ABNT
MACHADO NETO, João Agostinho et al. Stathmin 1 is involved in the highly proliferative phenotype of high-risk myelodysplastic syndromes and acute leukemia cells. 2013, Anais.. New Orleans: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, 2013. Disponível em: https://ash.confex.com/ash/2013/webprogram/Paper57514.html. Acesso em: 24 abr. 2024. -
APA
Machado Neto, J. A., Campos, P. de M., Favaro, P., Lazarini, M., Lorand-Metze, I., Costa, F. F., et al. (2013). Stathmin 1 is involved in the highly proliferative phenotype of high-risk myelodysplastic syndromes and acute leukemia cells. In Abstracts, Program and Personal Scheduler. New Orleans: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Recuperado de https://ash.confex.com/ash/2013/webprogram/Paper57514.html -
NLM
Machado Neto JA, Campos P de M, Favaro P, Lazarini M, Lorand-Metze I, Costa FF, Saad STO, Traina F. Stathmin 1 is involved in the highly proliferative phenotype of high-risk myelodysplastic syndromes and acute leukemia cells [Internet]. Abstracts, Program and Personal Scheduler. 2013 ;[citado 2024 abr. 24 ] Available from: https://ash.confex.com/ash/2013/webprogram/Paper57514.html -
Vancouver
Machado Neto JA, Campos P de M, Favaro P, Lazarini M, Lorand-Metze I, Costa FF, Saad STO, Traina F. Stathmin 1 is involved in the highly proliferative phenotype of high-risk myelodysplastic syndromes and acute leukemia cells [Internet]. Abstracts, Program and Personal Scheduler. 2013 ;[citado 2024 abr. 24 ] Available from: https://ash.confex.com/ash/2013/webprogram/Paper57514.html - FMNL1 is downregulated in myelodysplastic syndromes and is involved in megakaryocytic differentiation
- Increased inflammatory markers and their correlations to clinical complications in hemoglobin SC disease
- YAP1 expression in myelodysplastic syndromes and acute leukemias. [Carta]
- ANKHD1, a novel component of the Hippo signaling pathway, promotes YAP1 activation and cell cycle progression in prostate cancer cells
- Differential profile of PIP4K2A expression in hematological malignancies
- Abnormal Hedgehog pathway in myelodysplastic syndrome and its impact on patients' outcome. [Carta]
- Key endothelial cell angiogenic mechanisms are stimulated by the circulating milieu in sickle cell disease and attenuated by hydroxyurea
- IRS2 silencing increases apoptosis and potentiates the effects of ruxolitinib in JAK2V617F-positive myeloproliferative neoplasms
- Padronização da investigação laboratorial de anticorpos dirigidos contra fármacos em doadores de sangue e pacientes com anemia hemolítica imune
- MDR-1 and GST polymorphisms are involved in myelodysplasia progression
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
